Pineapple Inc. Provides Shareholder Update and 2025 Outlook
Pineapple Inc. (OTC: PNPL) has announced its strategic expansion into two new business segments: functional mushroom products and cannabis retail management. The company launched Shroomtropics, a new line of functional mushroom supplements available in three varieties: Relax, Mind & Body, and Performance, offered in gummy form at select retailers.
The company is also entering the cannabis retail management sector, overseeing existing management contracts in the Los Angeles market. This includes supporting Pineapple Consolidated Inc.'s expansion, which operates the Pineapple Express Hollywood dispensary and plans to launch four new locations.
Pineapple Inc.'s business portfolio includes:
- Property procurement and leasing for licensed cannabis operators
- Cannabis business management services
- Functional mushroom supplements through shroomtropics.com
- Hemp-derived CBD products via pineapplewellness.com
- Cannabis business licensing and consulting services through Pineapple Express Consulting
Pineapple Inc. (OTC: PNPL) ha annunciato la sua espansione strategica in due nuovi segmenti di business: prodotti a base di funghi funzionali e gestione del retail di cannabis. L'azienda ha lanciato Shroomtropics, una nuova linea di integratori a base di funghi funzionali disponibili in tre varianti: Relax, Mind & Body e Performance, offerti in forma di gomma presso rivenditori selezionati.
L'azienda sta anche entrando nel settore della gestione del retail di cannabis, supervisionando contratti di gestione esistenti nel mercato di Los Angeles. Questo include il supporto all'espansione di Pineapple Consolidated Inc., che gestisce il dispensario Pineapple Express Hollywood e prevede di aprire quattro nuove sedi.
Il portafoglio commerciale di Pineapple Inc. include:
- Acquisizione e leasing di proprietà per operatori di cannabis autorizzati
- Servizi di gestione aziendale per il settore cannabis
- Integratori a base di funghi funzionali tramite shroomtropics.com
- Prodotti CBD derivati dalla canapa tramite pineapplewellness.com
- Servizi di licenza e consulenza per il business della cannabis tramite Pineapple Express Consulting
Pineapple Inc. (OTC: PNPL) ha anunciado su expansión estratégica en dos nuevos segmentos de negocio: productos de hongos funcionales y gestión de retail de cannabis. La empresa lanzó Shroomtropics, una nueva línea de suplementos de hongos funcionales disponibles en tres variedades: Relax, Mind & Body y Performance, ofrecidos en forma de gomitas en minoristas seleccionados.
La empresa también está ingresando al sector de gestión de retail de cannabis, supervisando contratos de gestión existentes en el mercado de Los Ángeles. Esto incluye el apoyo a la expansión de Pineapple Consolidated Inc., que opera el dispensario Pineapple Express Hollywood y planea abrir cuatro nuevas ubicaciones.
El portafolio de negocios de Pineapple Inc. incluye:
- Adquisición y arrendamiento de propiedades para operadores de cannabis con licencia
- Servicios de gestión empresarial para el sector del cannabis
- Suplementos de hongos funcionales a través de shroomtropics.com
- Productos de CBD derivados del cáñamo a través de pineapplewellness.com
- Servicios de licencia y consultoría empresarial para cannabis a través de Pineapple Express Consulting
파인애플 주식회사 (OTC: PNPL)는 기능성 버섯 제품과 대마초 소매 관리라는 두 개의 새로운 사업 분야로 전략적 확장을 발표했습니다. 이 회사는 Shroomtropics라는 이름의 기능성 버섯 보충제 라인을 출시했으며, 세 가지 종류: Relax, Mind & Body, Performance로 제공되며, 선택된 소매점에서 젤리 형태로 판매됩니다.
회사는 또한 로스앤젤레스 시장에서 기존의 관리 계약을 감독하며 대마초 소매 관리 부문에 진출하고 있습니다. 여기에는 파인애플 통합 주식회사의 확장을 지원하는 것이 포함되며, 이 회사는 파인애플 익스프레스 할리우드 약국을 운영하고 있으며 네 개의 새로운 지점을 열 계획입니다.
파인애플 주식회사의 사업 포트폴리오에는 다음이 포함됩니다:
- 라이센스가 있는 대마초 운영자를 위한 부동산 조달 및 임대
- 대마초 사업 관리 서비스
- shroomtropics.com을 통한 기능성 버섯 보충제
- pineapplewellness.com을 통한 대마에서 유래한 CBD 제품
- Pineapple Express Consulting을 통한 대마초 사업 라이센스 및 컨설팅 서비스
Pineapple Inc. (OTC: PNPL) a annoncé son expansion stratégique dans deux nouveaux segments d'activité : les produits à base de champignons fonctionnels et la gestion du commerce de détail de cannabis. L'entreprise a lancé Shroomtropics, une nouvelle gamme de compléments alimentaires à base de champignons fonctionnels disponibles en trois variétés : Relax, Mind & Body et Performance, proposés sous forme de gommes dans des points de vente sélectionnés.
L'entreprise entre également dans le secteur de la gestion du commerce de détail de cannabis, supervisant des contrats de gestion existants sur le marché de Los Angeles. Cela inclut le soutien à l'expansion de Pineapple Consolidated Inc., qui exploite le dispensaire Pineapple Express Hollywood et prévoit d'ouvrir quatre nouveaux emplacements.
Le portefeuille commercial de Pineapple Inc. comprend:
- Acquisition et location de biens pour les opérateurs de cannabis agréés
- Services de gestion d'entreprise pour le secteur du cannabis
- Compléments alimentaires à base de champignons fonctionnels via shroomtropics.com
- Produits CBD dérivés du chanvre via pineapplewellness.com
- Services de licence et de conseil pour les entreprises de cannabis via Pineapple Express Consulting
Pineapple Inc. (OTC: PNPL) hat seine strategische Expansion in zwei neue Geschäftsbereiche angekündigt: funktionale Pilzprodukte und Cannabis-Einzelhandelsmanagement. Das Unternehmen hat Shroomtropics eingeführt, eine neue Linie von funktionalen Pilzergänzungen, die in drei Varianten erhältlich sind: Relax, Mind & Body und Performance, die in Form von Gummis bei ausgewählten Einzelhändlern angeboten werden.
Das Unternehmen tritt auch in den Bereich des Cannabis-Einzelhandelsmanagements ein und überwacht bestehende Managementverträge auf dem Markt in Los Angeles. Dazu gehört die Unterstützung der Expansion von Pineapple Consolidated Inc., die die Pineapple Express Hollywood-Apotheke betreibt und plant, vier neue Standorte zu eröffnen.
Das Geschäftsporfolio von Pineapple Inc. umfasst:
- Immobilienbeschaffung und -vermietung für lizenzierte Cannabisbetreiber
- Cannabis-Geschäftsmanagementdienste
- Funktionale Pilzergänzungen über shroomtropics.com
- CBD-Produkte aus Hanf über pineapplewellness.com
- Cannabis-Geschäftslizenzen und Beratungsdienste über Pineapple Express Consulting
- Diversification of revenue streams through expansion into functional mushroom products
- Entry into cannabis retail management with existing contracts in Los Angeles
- Planned expansion of retail footprint with four new locations
- Multiple established revenue channels across cannabis and wellness sectors
- Heavy reliance on newly launched, unproven product lines
- Operating in highly competitive and regulated cannabis market
- Dependency on Pineapple Consolidated Inc.'s success for retail management revenue
Company Expands into Cannabis Business Management and Functional Mushroom Markets to Drive Growth and Profitability
LOS ANGELES, CA, March 13, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “Company”) today announced its strategic expansion into the functional mushroom product sector and the cannabis retail management industry. These initiatives are designed to enhance revenue streams and strengthen long-term profitability.
The Company introduced its new line of functional mushroom products under the brand name Shroomtropics, with an accompanying website currently under development at shroomtropics.com. This venture is in collaboration with Pineapple Consolidated, Inc., the primary driver behind the product development.
Matthew Feinstein, Chairman of Pineapple, Inc., stated, “Our functional mushroom supplements are meticulously crafted, blending functional mushrooms with nootropics to support various wellness goals, including athletic performance, mental clarity, and relaxation. The product line, available in gummy form, includes three distinct varieties: Relax, Mind & Body, and Performance. These products are currently available for purchase at select retailers in our eco-system, with the full range to be showcased on our upcoming website.”
Additionally, Pineapple announced its entry into cannabis retail management. The Company will oversee and generate revenue from existing management contracts within the Los Angeles market.
“We are excited to support Pineapple Consolidated, Inc. as they expand their retail footprint,” Feinstein added. “Their flagship Pineapple Express Hollywood dispensary recently celebrated its third anniversary on the iconic Hollywood Walk of Fame. With four new locations set to launch in the coming months, we are committed to assisting their growth while benefiting from their ongoing success.”
About Pineapple, Inc.
Headquartered in Los Angeles, California, Pineapple, Inc. specializes in procuring and leasing properties to licensed cannabis operators, offering management services for cannabis businesses, and providing functional mushroom supplements through shroomtropics.com. Its wholly owned subsidiary, Pineapple Wellness, Inc., delivers nationwide hemp-derived CBD products via pineapplewellness.com. Additionally, Pineapple Express Consulting, Inc. provides cannabis business licensing and consulting services. Pineapple’s leadership team combines extensive corporate expertise with decades of experience navigating the highly regulated cannabis industry.
For more information, visit www.pineappleinc.com.
Forward-Looking Statements:
This release contains “forward-looking statements”. Forward-looking statements also may be included in other publicly available documents issued by PNPL and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Company Contact:
Matthew Feinstein, Director
Pineapple, Inc.
Office: 877-310-PNPL
FAQ
What new business segments is Pineapple Inc. (PNPL) expanding into in 2025?
What products does Shroomtropics offer under PNPL's new mushroom line?
How many new cannabis retail locations is PNPL planning to manage?
What are the main revenue streams for Pineapple Inc. (PNPL)?
